NCT06409936
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06409936
Title PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML (PEARL)
Acronym PEARL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital del Mar (Barcelona) RECRUITING Barcelona Spain Details
Hospital Universitario Basurto RECRUITING Bilbao Spain Details
Institut Català d'Oncologia Girona RECRUITING Girona Spain Details
Hospital Virgen de las Nieves RECRUITING Granada Spain Details
Hospital Universitario de Gran Canaria Dr. Negrín RECRUITING Las Palmas de Gran Canaria Spain Details
Hospital Gral U. Gregorio Marañón RECRUITING Madrid Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid Spain Details
Hospital Universitario La Paz RECRUITING Madrid Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca RECRUITING Murcia Spain Details
Complejo Asistencial Universitario de Salamanca RECRUITING Salamanca Spain Details
Hospital Universitario La Fe Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field